Immunohistological features of visceral leishmaniasis in BALB/c mice. 2006

J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
Centro de Biología Molecular Severo Ochoa, Universidad Autónoma de Madrid, Madrid, Spain.

It has been reported that the level of protection provided by vaccines against murine visceral leishmaniasis (VL) is low and that progress in research on VL may be due to the lack of appropriate models to study protective immunity. We have analysed the immunohistological features occurring in BALB/c mice after intravenous administration of 10(3), 10(5) and 10(6) parasites of Leishmania infantum. Our results show that in all cases parasite administration leads to the establishment of infection and to the development of quantifiable immunohistological features which are dependent on the inoculum size. This study demonstrates that differences in the parasite challenge result in changes in the evolution of some of the parameters associated with the degree of the infection in the BALB/c model: level of anti-Leishmania antibodies, up-regulation of spleen arginase activity, balance between IFN-gamma and IL-10, extent of lymphoid follicle depletion in the splenic white pulp and ineffective development of hepatic granulomas. Also, and depending on the initial infectious inoculum, the absence of parasites in the bone marrow and the number of mature and empty type granulomas were parameters associated with protection. We think that in this model a challenge of the order of 10(5) parasites should prove useful for vaccine studies against VL.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006400 Hematocrit The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value. Erythrocyte Volume, Packed,Packed Red-Cell Volume,Erythrocyte Volumes, Packed,Hematocrits,Packed Erythrocyte Volume,Packed Erythrocyte Volumes,Packed Red Cell Volume,Packed Red-Cell Volumes,Red-Cell Volume, Packed,Red-Cell Volumes, Packed,Volume, Packed Erythrocyte,Volume, Packed Red-Cell,Volumes, Packed Erythrocyte,Volumes, Packed Red-Cell
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
July 2016, Journal of biomedical research,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
April 1977, Infection and immunity,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
March 2021, Immunobiology,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
December 1998, European cytokine network,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
September 2021, Microbial pathogenesis,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
April 2001, Vaccine,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
January 2019, Wellcome open research,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
February 1996, The American journal of tropical medicine and hygiene,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
January 2019, Frontiers in immunology,
J Carrión, and A Nieto, and S Iborra, and V Iniesta, and M Soto, and C Folgueira, and D R Abanades, and J M Requena, and C Alonso
May 2021, Vaccine,
Copied contents to your clipboard!